Premium
Pretreatment clinical and genetic factors predict early post‐treatment mortality in fit AML patients following induction
Author(s) -
Haydu J. Erika,
Flamand Yael,
Vedula Rahul S.,
Versluis Jurjen,
Charles Anne,
Copson Kevin M.,
Stone Richard M.,
DeAngelo Daniel J.,
Neuberg Donna,
Lindsley R. Coleman,
Luskin Marlise R.
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26188
Subject(s) - medicine , induction chemotherapy , cytarabine , hematopoietic stem cell transplantation , chemotherapy , population , myeloid leukemia , chemotherapy regimen , transplantation , oncology , surgery , environmental health